Clinical Trial

Advanced Therapeutics in Rheumatoid Arthritis (RA)

Study Description

Advanced Therapeutics in Rheumatoid Arthritis (RA)

This study will evaluate the retention rates of two advanced therapies, Tumour Necrosis Factor (TNF) and Janus kinase inhibitor (JAK) in the treatment of adults with Rheumatoid Arthritis (RA) over a two year period. It will also examine the ability to embed a clinical trial in a clinical situation using an electronic medical record (EMR).

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Etanercept

injection

Drug - tofacitinib

tablet

Additional Information

Official Study Title

Advanced Therapeutics in Rheumatoid Arthritis (RA)

Clinical Trial ID

NCT03976245

ParticipAid ID

ejR9ve